Send Press Release To Your Friends

PR Title:	Novartis studies show Onbrez® Breezhaler® plus tiotropium is more effective than tiotropium alone in treatment of COPD
PR Summary:	Results of two Phase III studies show that once-daily Onbrez® Breezhaler® (indacaterol) plus tiotropium produced a significantly greater improvement in lung function than tiotropium alone in patients with chronic obstructive pulmonary disease (COPD)[1], supporting current treatment guidelines which recommend use of one or more bronchodilators for treating moderate-to-severe disease[2].

	Basic Information
	Your Name* Your Email* Friend's Name Friend's Email 1* 2   3   Your Message